Renk's shares fall 51% from peak despite €7.4B orders; Q2 EPS halves, raising margin concerns amid sector quality issues.

There is a peculiar arithmetic at work in the defense sector right now: the numbers look spectacular, yet the share price ...

The arithmetic of Shell's current strategy is striking in its symmetry. On one side sits a freshly completed C$16.5bn ...

Evotec partners with Plectonic on solid tumors, but shares slip below 50-day MA, trading near EUR 3.35, down 39% YTD amid ...

There is a peculiar tension at the heart of Micron Technology's current market position. The company is posting revenue growth that would make most semiconducto ...

The gap between Plug Power's operational story and its stock chart has rarely been wider. Since the shares touched a 52-week high of EUR 4.04 last October, they ...

The arithmetic of Ubtech Robotics' turnaround story is striking on paper. First-half 2026 revenue hit 1.269 billion yuan, up 104 percent year on year, while net ...

European Lithium's takeover by Critical Metals Corp features a variable exchange ratio, currently favorable, with court ...

The most consequential news out of First Phosphate this week had nothing to do with the annual shareholder meeting that took ...

Income-focused investors tracking the VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF have a date with the distribution calendar this week, even ...

Renk's shares trade 52% below peak despite record orders and capacity expansion, as investors await David Brown deal closure.

Commerzbank concedes to UniCredit's advance; CEO Orlopp may step down if no deal, while Berlin's stake sale could reshape ownership.